Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS

Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS

ABSTRACT Objective To investigate the impact of epidemiological and clinical factors on the benefit of riluzole in patients with amyotrophic lateral sclerosis (ALS). Methods The survival rate of 578 patients with ALS (1999-2011) was analyzed by descriptive statistics and Kaplan-Meier curves. Con...

Full description

Bibliographic Details
Main Authors:	Francis Meire Fávero, Mariana Callil Voos, Isac de Castro, Fátima Aparecida Caromano, Acary Souza Bulle Oliveira
Format:	Article
Language:	English
Published:	Academia Brasileira de Neurologia (ABNEURO)
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	epidemiology amyotrophic lateral sclerosis motor neuron disease survival riluzole
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2017000800515&lng=en&tlng=en

Similar Items

Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis
by: Mónica Povedano Panades, et al.
Published: (2021-07-01)

Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis
by: Dyer AM, et al.
Published: (2016-12-01)

Analysis of riluzole’s profile of use in a Central Hospital in Lisbon
by: Paróla A, et al.
Published: (2018-11-01)

Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients
by: Xueping Chen, et al.
Published: (2018-06-01)

Long-term use of riluzole could improve the prognosis of sporadic amyotrophic lateral sclerosis patients: a real-world cohort study in China
by: Lu Chen, et al.
Published: (2016-10-01)

Biomaterials in The Treatment of Amyotrophic Lateral Sclerosis
by: Fardin Nabizadeh
Published: (2022-06-01)

Combined Treatment with Bojungikgi-Tang and Riluzole Regulates Muscle Metabolism and Dysfunction in the hSOD1<sup>G93A</sup> Mouse Model
by: Mudan Cai, et al.
Published: (2022-03-01)

Development of a robust UPLC-MS/MS method for the quantification of riluzole in human plasma and its application in pharmacokinetics
by: Zhuo Sun, et al.
Published: (2023-08-01)

Pneumomediastinum while using mechanical insufflation-exsufflation after recovery from riluzole-induced interstitial lung disease
by: Yuji Saitoh, et al.
Published: (2021-03-01)

Interstitial pneumonia and other adverse events in riluzole-administered amyotrophic lateral sclerosis patients: a retrospective observational study
by: Aya Inoue-Shibui, et al.
Published: (2019-04-01)

From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies
by: Serge Mignani, et al.
Published: (2020-07-01)

Amyotrophic lateral sclerosis – aetiology, diagnostics and multidirectional, team, long-term care
by: Kamila Tuzim, et al.
Published: (2018-08-01)

Amyotrophic lateral sclerosis – aetiology, diagnostics and multidirectional, team, long-term care
by: Kamila Tuzim, et al.
Published: (2018-08-01)

Riluzole Ameliorates Harmaline-Induced Tremor in Rat
by: Fatemeh Rahimi Shourmasti, et al.
Published: (2014-05-01)

Combined Treatment with Herbal Medicine and Drug Ameliorates Inflammation and Metabolic Abnormalities in the Liver of an Amyotrophic Lateral Sclerosis Mouse Model
by: Hee Ra Park, et al.
Published: (2022-01-01)

Far beyond the motor neuron: the role of glial cells in amyotrophic lateral sclerosis
by: Paulo Victor Sgobbi de Souza, et al.

Assessment of therapeutic response of edaravone and riluzole combination therapy in amyotrophic lateral sclerosis patients
by: Swapnil Samadhiya, et al.
Published: (2022-01-01)

Anthropometry of arm: nutritional risk indicator in amyotrophic lateral sclerosis
by: Cristina Cleide dos Santos Salvioni, et al.
Published: (2015-12-01)

New insight into the effect of riluzole on cadmium tolerance and accumulation in duckweed (Lemna turionifera)
by: Lin Yang, et al.
Published: (2022-08-01)

Clinical and Genetic Aspects of Juvenile Amyotrophic Lateral Sclerosis: A Promising Era Emerges
by: Paulo Victor Sgobbi de Souza, et al.
Published: (2024-02-01)

Use of Riluzole for the Treatment of Hereditary Ataxias: A Systematic Review
by: Iván Nicolas Ayala, et al.
Published: (2022-08-01)

Safety and Efficacy of Riluzole in Traumatic Spinal Cord Injury: A Systematic Review With Meta-Analyses
by: Luke J. Weisbrod, et al.
Published: (2024-02-01)

A Clinical Scale for Rating the Severity of Bulbar Lower Motor Neuron Dysfunction in Amyotrophic Lateral Sclerosis
by: Stefano Zoccolella, et al.
Published: (2023-07-01)

The Effects of Riluzole on Cisplatin-induced Ototoxicity
by: Selin Üstün Bezgin, et al.
Published: (2019-03-01)

Amyotrophic lateral sclerosis (ALS): three letters that change the people's life. For ever Esclerose lateral amiotrófica (ELA): três letras que mudam a vida de uma pessoa. Para sempre
by: Acary Souza Bulle Oliveira, et al.
Published: (2009-09-01)

Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review
by: Yoshitaka Kawashima, et al.
Published: (2023-09-01)

Improved Long-Term Survival with Edaravone Therapy in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Single-Center Study in Japan
by: Hideki Houzen, et al.
Published: (2021-07-01)

Computational Insights into The Neuroprotective Action of Riluzole on 3-Acetylpyridine-Induced Ataxia in Rats
by: Mahyar Janahmadi, et al.
Published: (2013-01-01)

The effect of Riluzole on neurological outcomes, blood-brain barrier, brain water and neuroinflammation in traumatic brain injury
by: Atabak nikbakht, et al.
Published: (2022-12-01)

Amyotrophic lateral sclerosis in Slovenia – analysis of patient population at the Ljubljana Institute of Clinical Neurophysiology
by: Mojca Kirbiš, et al.
Published: (2015-09-01)

Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis
by: Wei-Ming Su, et al.
Published: (2022-06-01)

Brazilian Nursing and Psychology students' visits to patients with amyotrophic lateral sclerosis: prospective analysis
by: Antonio Geraldo Abreu Filho, et al.
Published: (2019-12-01)

Telehealth for amyotrophic lateral sclerosis in a multidisciplinary service in a Brazilian reference center
by: Emanuela Coriolano Fidelix, et al.
Published: (2023-05-01)

Cell targeted phenotyping: understanding molecular genetic mechanisms of C9ORF72 ALS in motor neurons
by: Burley, S
Published: (2018)

Esclerosis lateral amiotrófica. Una revisión crítica sobre su tratamiento con riluzole
by: Alexander
Published: (2007-07-01)

Esclerosis lateral amiotrófica. Una revisión crítica sobre su tratamiento con riluzole
by: Alexander
Published: (2007-07-01)

A preliminary evaluation of comparative effectiveness of riluzole in therapeutic regimen for irritable bowel syndrome
by: Surya Prakash Mishra, et al.
Published: (2014-05-01)

MRI data confirm the selective involvement of thalamic and amygdalar nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis
by: Rangariroyashe H. Chipika, et al.
Published: (2020-10-01)

Sporadic amyotrophic lateral sclerosis: is SMN-Gemins protein complex of importance for the relative resistance of oculomotor nucleus motoneurons to degeneration?
by: Dorota Sulejczak, et al.
Published: (2018-12-01)

The Impact of Microbiota on the Pathogenesis of Amyotrophic Lateral Sclerosis and the Possible Benefits of Polyphenols. An Overview
by: Julia Casani-Cubel, et al.
Published: (2021-02-01)